Chemomab Therapeutics Ltd. American Depositary Share (CMMB)
Stock · NASDAQ · Health Care
$2.7as of 8/28/2026
Price chart
Open in TradingViewAbout CMMB
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating prima…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.chemomab.com/
Fundamentals
- 1-day range
- $1.83$2.04
- Market cap
- $12.95M
- P/E (trailing)
- —
- P/E (forward)
- -64.33
- EPS (trailing)
- $-0.01
- Dividend yield
- —
- Beta
- 0.72
- Avg. volume
- 133.0K
52-week range
$1.35$3.63
Next earnings: May 14, 2026confirmed
Forecasts
1 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$5
+85.2%
Median
$5
+85.2%
Low
$5
+85.2%
Chemomab Therapeutics Ltd. American Depositary Share Competitors
Chosen by industry and closest market cap.
- CMMBChemomab Therapeutics Ltd. American Depositary Share$2.7▼ 0.74%Market cap $12.95MP/E —$1.35$3.63
- PBMPsyence Biomedical Ltd. Common Shares$4.21▼ 3.44%Market cap $13.31MP/E —$1.92$216.37
- PHIOPhio Pharmaceuticals Corp. Common Stock$1.13▲ 0.45%Market cap $12.31MP/E —$0.8127$4.19
- BLRXBioLineRx Ltd. American Depositary Shares$2.61▼ 5.43%Market cap $12.14MP/E Infinity$1.1$2.4
- AEONAEON Biopharma Inc. Class A Common Stock$0.3095▲ 5.27%Market cap $13.80MP/E —$0.1772$1.45
- AKTXAkari Therapeutics plc ADS$11.03▲ 22.42%Market cap $14.14MP/E Infinity$3.02$49.6
- COCPCocrystal Pharma Inc. Common Stock$1.11▼ 2.63%Market cap $14.20MP/E —$0.76$2.67
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics Ltd. American Depositary Share | $12.95M | — | $2.7 | ▼ 0.74% | $1.35$3.63 |
| PBM Psyence Biomedical Ltd. Common Shares | $13.31M | — | $4.21 | ▼ 3.44% | $1.92$216.37 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $12.31M | — | $1.13 | ▲ 0.45% | $0.8127$4.19 |
| BLRX BioLineRx Ltd. American Depositary Shares | $12.14M | Infinity | $2.61 | ▼ 5.43% | $1.1$2.4 |
| AEON AEON Biopharma Inc. Class A Common Stock | $13.80M | — | $0.3095 | ▲ 5.27% | $0.1772$1.45 |
| AKTX Akari Therapeutics plc ADS | $14.14M | Infinity | $11.03 | ▲ 22.42% | $3.02$49.6 |
| COCP Cocrystal Pharma Inc. Common Stock | $14.20M | — | $1.11 | ▼ 2.63% | $0.76$2.67 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CORRECTION: Chemomab Therapeutics Q2 EPADS $(0.27) Misses $(0.15) Estimatebenzinga · 8/19/2026
- CORRECTION: Chemomab Therapeutics Q2 EPADS $(0.27) Misses $(0.15) EstimateBenzinga · 8/19/2026
Insider Activity
Insider Actions →Acquired
0
Disposed
60.3K
- George Adi Mor · May 29, 2026 · J18.8K
- George Adi Mor · May 29, 2026 · J31.7K
- George Adi Mor · May 29, 2026 · Buy4.9K @ $2.08
- George Adi Mor · May 29, 2026 · Buy4.9K @ $2.05
Institutional Ownership
March 31, 2026
- Total shares held
- 351.6K
- Total value held
- $551.9K
- Institutional holders
- 15
Top holders this quarter
- Unknown80.0K
- Unknown64.2K
- Unknown61.7K
- Unknown51.8K
- Unknown18.6K
- Unknown18.4K
- Unknown14.6K
- Unknown13.5K
- Unknown8.4K
- Unknown8.2K
See the full, filterable feed with live charts on the MarketWall dashboard.